China: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in China

The Chinese prophylactic medicaments containing insulin market stood at $X in 2022, with an increase of 6.1% against the previous year. Over the period under review, consumption saw a resilient expansion. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in China

In value terms, prophylactic medicaments containing insulin production expanded markedly to $X in 2022 estimated in export price. In general, production continues to indicate buoyant growth. The most prominent rate of growth was recorded in 2013 with an increase of 42%. Prophylactic medicaments containing insulin production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from China

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from China; dropping by -13% on 2021 figures. Over the period under review, exports, however, showed a significant increase. The most prominent rate of growth was recorded in 2013 with an increase of 202%. The exports peaked at X tons in 2021, and then reduced in the following year.

In value terms, prophylactic medicaments containing insulin exports shrank sharply to $X in 2022. In general, exports, however, showed a significant increase. The pace of growth was the most pronounced in 2013 with an increase of 273%. The exports peaked at $X in 2021, and then fell dramatically in the following year.

Exports by Country

Denmark (X tons), Brazil (X tons) and France (X tons) were the main destinations of prophylactic medicaments containing insulin exports from China, together comprising 89% of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Brazil (with a CAGR of +764.3%), while the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X), France ($X) and Brazil ($X) were the largest markets for prophylactic medicaments containing insulin exported from China worldwide, together accounting for 93% of total exports.

Among the main countries of destination, Brazil, with a CAGR of +622.3%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, dropping by -8.6% against the previous year. Over the period under review, export price indicated noticeable growth from 2012 to 2022: its price increased at an average annual rate of +4.4% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price decreased by -13.7% against 2020 indices. The most prominent rate of growth was recorded in 2020 an increase of 38% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2021 to 2022, the average export prices remained at a lower figure.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was France ($X per ton), while the average price for exports to Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to France (+17.8%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into China

In 2022, after four years of growth, there was significant decline in supplies from abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -51.7% to X tons. Over the period under review, imports continue to indicate a noticeable downturn. The pace of growth appeared the most rapid in 2013 with an increase of 38%. Over the period under review, imports attained the peak figure at X tons in 2021, and then contracted markedly in the following year.

In value terms, prophylactic medicaments containing insulin imports dropped rapidly to $X in 2022. Overall, imports continue to indicate a deep slump. The most prominent rate of growth was recorded in 2013 when imports increased by 18%. Over the period under review, imports reached the maximum at $X in 2021, and then shrank notably in the following year.

Imports by Country

Denmark (X tons), Italy (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to China, with a combined 79% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Italy (with a CAGR of +285.3%), while imports for the other leaders experienced mixed trend patterns.

In value terms, the largest prophylactic medicaments containing insulin suppliers to China were Denmark ($X), Germany ($X) and Italy ($X), with a combined 83% share of total imports.

Italy, with a CAGR of +274.2%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, falling by -23.9% against the previous year. Overall, the import price saw a pronounced descent. The growth pace was the most rapid in 2017 when the average import price increased by 18% against the previous year. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per ton), while the price for Poland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+17.3%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :